Medical Director, Abbott, Medical and Scientific Affairs
BIOGRAPHY
Speaker
Abstract
Myelodysplastic Syndrome (MDS) requires a complicated workup that can be supported by Artificial Intelligence (AI). Initial findings using AI have shown that MDS can be preliminarily identified with the data from an automated hematology analyzer.
Learning Objectives
- Discuss the fundamentals of Artificial Intelligence.
- Identify the utility of AI in the workup of MDS.
- Demonstrate how AI can be utilized using the data from a hematology analyzer in the evaluation of MDS.
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...